Parexel has posted strong financial results for the fourth quarter
of its fiscal year while it is finally starting to reap the fruits
of its labour in the medical communications business.
Novo Nordisk has reported a 60 per cent jump in pre-tax profit to
DK6.8bn (€0.9bn) for the first half of 2007, boosted by the earlier
sale of its cancer diagnostics business.
Applied Biosystems (ABI) passed the $2bn (€1.46bn) revenue mark
during 2007; however profits took a hit due to the acquisition of
next generation DNA sequencing technology.
Laboratory equipment manufacturers have been doing well in the
first half of 2007, with Thermo Fisher Scientific, Waters,
Affymetrix and PerkinElmer all achieving near double digit growth.
PRA said it signed an agreement with equity firm Genstar Capital to
be bought back by the firm for around $790m (€580m) while the CRO
posted a 90 per cent tumble in profit in Q2 due to heavy
restructuring charges.
PPD has posted positive financial results for the second quarter of
the year in net contrast to its lacklustre performance in Q1, but
cut its earning outlook for the full year.
Pfizer, Novartis and Sanofi-Aventis were the companies who
attracted the most interest from pharmaceutical business
researchers in the first half of the year, according to a UK pharma
market research firm.
LabTechnologist.com brings you an exclusive interview with Chris
van Ingen - the president of Agilent's Life Science and Chemical
Analysis (LSCA) division.
Charles River has posted first quarter results that beat analysts
expectations after seeing renewed growth in its research models and
services segment.
One-off costs related to last year's acquisition of Serologicals
and a continuing manufacturing consolidation strategy were largely
responsible for sharp falls in Millipore's pre-tax and net profits
for the first quarter...
Laboratory equipment manufacturers are having a good start to 2007,
with Thermo Fisher Scientific, Applied Biosystems, Waters, Varian
and PerkinElmer nearly all achieving double-digit revenue growth.
Biotech giant Amgen has posted healthy results for the first
quarter following a positive performance by its blockbuster anaemia
drug Aranesp (darbepoetin alfa).
An increasing number of factors are luring sponsors to offshore
clinical trials to 'hidden gems' across the globe, delegates heard
at this week's Accelerating Patient Recruitment & Retention in
Clinical Trials conference,...
Genentech, the world's second biggest biotech company, has shown a
strong performance in the first quarter while its main rival Amgen
is trying to regain momentum after a difficult year.
Icon has announced strong financial results for the fourth quarter
of 2006, driven by the improved profitability of its Clinical and
Central Lab segments.
Parexel has announced encouraging financial results for its second
fiscal quarter, despite 'disappointing' performance in its medical
communications business.
More companies in the pharmaceutical industry than any other
industry are set to increase their reliance on information
technology (IT) and business process (BP) outsourcing this year,
new research indicates.
A new report out this week suggests the pharma industry is losing
the trust of its key stakeholders. The report, compiled by
PricewaterhouseCoopers (PwC), concludes that the growing decline in
the pharmaceutical industry's reputation...
Although US spending on healthcare rose by 6.9 per cent in 2005,
taking it to almost $2 trillion (€1.5 trillion), it's the smallest
increase since 1999, down from 7.2 per cent in 2004 and 8.1 per
cent in 2003.
The contract research organisation (CRO) industry is in full swing
as the clinical trial outsourcing trend continues, but where is the
money being spent?
Massachusetts-based Millipore has reported a fall in net profit in
its third quarter results, mainly due to increased costs and recent
acquisition charges.
Italian pharmaceutical company Recordati has reported a net profit
growth of 6.5 per cent to €18.5m in its third quarter results, as a
slump in sales was offset by lower costs.
A recent report that focuses on international research and
development trends has placed China as the country gaining
significant grounds on the US in terms of R&D spending and
outsourcing capabilities.
Thermo Electron has continued to show strong growth in the third
quarter 2006 buoyed on by strong returns in its mass spectrometry
business and progress in its Triple Quad technology.
Fresh from Thermo's $10.4bn (€8.3bn) acquisition of the scientific
equipment and instrument specialists, Fisher Scientific posted
strong third quarter results that showed a profit rise of 62 per
cent coupled with an 11 per cent...
Two trade associations of the world's two largest pharma economies
- Europe and the US - took the unusual step of banding together at
the CPhI in Paris to condemn their regulatory authorities for poor
regulation of foreign active...
Portuguese drug producers are small and need to merge or form
alliances to compete at a global level, investing more in
innovation and increasing their competitiveness like custom
manufacturer Hovione has done, a new report by market...
Difficulties in identifying tablets have emerged as a major issue
in a recent US survey of 150 pharmacists who are warning drugmakers
that the lack of distinct appearance in pills leads in dispensing
errors that cost more than 7,000...
Europe's third party logistics providers (3PL) are evolving to
integrate more of their operations with those of their clients in a
bid to provide a more efficient service, leaving the old breed in
danger of becoming extinct.
Italian packaging and processing machinery company IMA Group has
posted a net profit of €13m for 2005, down 24 per cent from 2004,
since a rise in revenues was offset by one-off charges, operating
costs and a reduction in prices as...
According to a new report, the pharmaceutical market grew seven per
cent, to $602 billion (€501 billion) in 2005. The report
highlighted the emerging markets including China, Korea, Mexico,
Russia and Turkey, which experienced double-digit...
Despite a dip in revenue, PRA International saw its profit grow 53
per cent in the fourth quarter of 2005 to reach $7.5m (€6.3m) on
the back of improved margins. The global clinical research
organization (CRO) also saw a similar growth...
Increased sales and price hikes helped BASF achieve record earnings
in 2005, despite substantially higher raw material prices, Europe's
subdued economy and hurricanes in the US.
Quest Diagnostics, the US's leading provider of diagnostic testing,
information and services announced better than expected fourth
quarter results after increased clinical testing activity helped to
offset a weakness in its test...
French pharmaceutical company, Sanofi-Aventis, reported an increase
in sales for the fourth quarter with its vaccine business
continuing to impress. The company's performance precedes two
upcoming decisions later this year that...
Covance closed 2005 on a high after net revenues climbed 16.9 per
cent from 2004 to reach $1.19 bn (€1 bn). The current trend towards
outsourcing R&D, coupled with increased productivity and repeat
business has fuelled the company's...
Drug production company Patheon has released its fourth-quarter
results, which has revealed that profit has jumped 180 per cent
despite a recent production halt at a Puerto Rican subsidiary. This
bodes well for the recent manufacturing...
Filtration system Pall Corporation reported its first quarter
earnings which revealed earnings rose by 16 per cent, propelled by
growth in its industrial and biopharmaceuticals segments.
Chemical company Lanxess, release its third quarter results that
show restructuring strategy is bearing fruit, with sales up and the
reduction of net financial debt that is supported by strong growth
in the chemical industry.
